Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial

This study was designed to determine whether intensive lifestyle intervention (ILI) aimed at weight loss lowers cancer incidence and mortality.

[1]  T. Byers,et al.  Does intentional weight loss reduce cancer risk? , 2011, Diabetes, obesity & metabolism.

[2]  W. Demark-Wahnefried,et al.  Obesity, Energy Balance, and Cancer: New Opportunities for Prevention , 2012, Cancer Prevention Research.

[3]  Jacqueline Wesche-Thobaben.  The development and description of the comparison group in the Look AHEAD trial , 2011, Clinical trials.

[4]  A. McTiernan,et al.  Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial. , 2016, Cancer research.

[5]  C. Mantzoros,et al.  Inflammation: A key player linking obesity with malignancies. , 2018, Metabolism: clinical and experimental.

[6]  M. Thun,et al.  Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. , 2004, American journal of epidemiology.

[7]  Karen C Johnson,et al.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. , 2003, Controlled clinical trials.

[8]  P. Goodwin,et al.  Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Ioannidis,et al.  Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.

[10]  P. Peeters,et al.  Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[11]  C. Ulrich,et al.  Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. , 2011, American journal of preventive medicine.

[12]  Xiaolin Wang,et al.  Body Mass Index and Risk of Gastric Cancer: A Meta-analysis of a Population with More Than Ten Million from 24 Prospective Studies , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[13]  W. Willett,et al.  Adult Weight Change and Risk of Postmenopausal Breast Cancer , 2006, Journal of the American Medical Association (JAMA).

[14]  C. Bouchard,et al.  Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. , 2009, The Lancet. Oncology.

[15]  Jianjun Luo,et al.  Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. , 2012, European journal of cancer.

[16]  J. Manson,et al.  Intentional Weight Loss and Obesity-Related Cancer Risk , 2019, JNCI cancer spectrum.

[17]  P. Peeters,et al.  Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial , 2015, Breast Cancer Research.

[18]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[19]  E. Calle,et al.  Cancer Incidence and Mortality After Gastric Bypass Surgery , 2009, Obesity.

[20]  T. Wadden,et al.  The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It , 2006, Obesity.

[21]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[22]  F. Hu,et al.  Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis , 2013, Surgical Endoscopy.

[23]  A. McTiernan,et al.  Dietary Weight Loss, Exercise, and Oxidative Stress in Postmenopausal Women: A Randomized Controlled Trial , 2016, Cancer Prevention Research.

[24]  Samy Suissa,et al.  Metformin and the Risk of Cancer , 2012, Diabetes Care.

[25]  C. Mantzoros,et al.  The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications , 2002, Oncology.

[26]  G. Bray,et al.  Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. , 2013, The New England journal of medicine.

[27]  George A. Bray,et al.  Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study , 2006, Diabetes & vascular disease research.

[28]  A. McTiernan,et al.  Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  F. Greenway,et al.  Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. , 2014, The lancet. Diabetes & endocrinology.

[30]  P. A. van den Brandt,et al.  A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk , 2011, International journal of cancer.

[31]  T. Wadden,et al.  Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design , 2017, npj Breast Cancer.

[32]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[33]  Yongzhi Yang,et al.  Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies , 2013, PloS one.

[34]  C. Ulrich,et al.  Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. , 2012, Cancer research.

[35]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[36]  N. Freedman,et al.  Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium , 2012, International journal of epidemiology.

[37]  Yinghua Xu,et al.  Body mass index and risk of renal cell cancer: A dose‐response meta‐analysis of published cohort studies , 2014, International journal of cancer.

[38]  A. Leonard,et al.  Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort , 2017, Annals of surgery.

[39]  M. Zwahlen,et al.  Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[40]  Jennette P. Moreno,et al.  Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2014, Current Atherosclerosis Reports.

[41]  E. Platz,et al.  A Prospective Study of the Associations Between Treated Diabetes and Cancer Outcomes , 2011, Diabetes Care.